Unknown

Dataset Information

0

Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.


ABSTRACT:

Introduction

Many people with long COVID symptoms suffer from debilitating neurologic post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC). Although symptoms of Neuro-PASC are widely documented, it is still unclear whether PASC symptoms impact virus-specific immune responses. Therefore, we examined T cell and antibody responses to SARS-CoV-2 Nucleocapsid protein to identify activation signatures distinguishing Neuro-PASC patients from healthy COVID convalescents.

Results

We report that Neuro-PASC patients exhibit distinct immunological signatures composed of elevated CD4+ T cell responses and diminished CD8+ memory T cell activation toward the C-terminal region of SARS-CoV-2 Nucleocapsid protein when examined both functionally and using TCR sequencing. CD8+ T cell production of IL-6 correlated with increased plasma IL-6 levels as well as heightened severity of neurologic symptoms, including pain. Elevated plasma immunoregulatory and reduced pro-inflammatory and antiviral response signatures were evident in Neuro-PASC patients compared with COVID convalescent controls without lasting symptoms, correlating with worse neurocognitive dysfunction.

Discussion

We conclude that these data provide new insight into the impact of virus-specific cellular immunity on the pathogenesis of long COVID and pave the way for the rational design of predictive biomarkers and therapeutic interventions.

SUBMITTER: Visvabharathy L 

PROVIDER: S-EPMC10258318 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.

Visvabharathy Lavanya L   Hanson Barbara A BA   Orban Zachary S ZS   Lim Patrick H PH   Palacio Nicole M NM   Jimenez Millenia M   Clark Jeffrey R JR   Graham Edith L EL   Liotta Eric M EM   Tachas George G   Penaloza-MacMaster Pablo P   Koralnik Igor J IJ  

Frontiers in immunology 20230529


<h4>Introduction</h4>Many people with long COVID symptoms suffer from debilitating neurologic post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC). Although symptoms of Neuro-PASC are widely documented, it is still unclear whether PASC symptoms impact virus-specific immune responses. Therefore, we examined T cell and antibody responses to SARS-CoV-2 Nucleocapsid protein to identify activation signatures distinguishing Neuro-PASC patients from healthy COVID convalescents.<h4>Results</h4>We re  ...[more]

Similar Datasets

2023-05-24 | GSE225942 | GEO
| PRJNA938055 | ENA
| S-EPMC11374748 | biostudies-literature
| S-EPMC9525112 | biostudies-literature
| S-EPMC11920441 | biostudies-literature
| S-EPMC9667737 | biostudies-literature
| S-EPMC10061413 | biostudies-literature
| S-EPMC10731459 | biostudies-literature
| S-EPMC7227795 | biostudies-literature
| S-EPMC3499516 | biostudies-literature